KRAS and lung carcinoma: While the loss of Keap1 fosters KRAS (a proto-oncogene GTPase)-mediated lung cancer, previous studies proved Nrf2-driven protection in vivo against carcinogen-induced lung cancer [109,118,119,120,121].